Description Whilst following in the footsteps of previous volumes by presenting comprehensive reviews of drug substances and additional materials,
this title also heralds a significant expansion of the scope of the series. Traditional contributions are now augmented by publication
of critical review chapters that summarize information related to the characterization of drug substances and excipients. This change
meets the needs of the pharmaceutical community and allows the development of a timely vehicle for publishing review materials on this
topic. While offering comprehensive and specialised chapters, Profiles of Drug Substances, Excipients and Related Methodology,
Volume 32 also presents a methodology review article on the validation of chromatographic methods of analysis, as well as a
summary of the publications in 2004 that dealt with polymorphism and solvatomorphism.
Audience
Medicinal, pharmaceutical, and analytical chemists; pharmacologists
Contents
Profiles of Drug Substances
1. Miconazole Nitrate
Comprehensive Profile (Abdullah A. Al-Badr).
2. Niclosamide
Comprehensive Profile (Badraddin M.H. Al-Hadiya).
3. Oxytetracycline
Analytical Profile (Mochammad Yuwono, Gunawan Indrayanto).
4. Penicillamine
4A Physical Profile
4B Analytical Profile
4C ADME Profile
(Abdulrahman Al-Majed et al.).
5. Primaquine Diphosphate
Comprehensive Profile (Abdullah A. Al-Badr).
6. Valproic Acid and Sodium Valproate
Comprehensive
Profile (Ibrahim A. Alsarra et al.).
Related Methodology Review Article
7. Validation of Chromatographic
Methods of Analysis (Mochammad Yuwono, Gunawan Indrayanto).
Annual Review
8. Polymorphism and Solvatomorphism
2004 (Harry G. Brittain).
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company